Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06342973 · ClinicalTrials.gov registry record · Phase 4
Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study
A Phase 4 study of Alveolar Ridge Deficiency, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT06342973: Completed Phase 4 study of Alveolar Ridge Deficiency, sponsored by Louisiana State University Health Sciences Center in New Orleans.
NCT06342973 is a Phase 4 study of Alveolar Ridge Deficiency that has completed, run by Louisiana State University Health Sciences Center in New Orleans. The registered enrollment target is 15 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06342973, a Phase 4 study of Alveolar Ridge Deficiency, has completed, sponsored by Louisiana State University Health Sciences Center in New Orleans.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this case series is to evaluate the outcomes of horizontal ridge augmentation performed using a combination of demineralized freeze-dried bone allograft layered with xenograft bone with a resorbable native collagen membrane.
Primary Outcome
Horizontal bone gain will be measured from post operative CBCT scans taken 6-9 months following the procedure
Conditions Studied
Interventions
- DEVICE Xenograft and allograft
Study Locations (1)
Louisiana
- LSUHSC School of Dentistry - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2024-03-27 |
| Est. Completion | 2025-10-15 |
| Phase | Phase 4 |
What the finished NCT06342973 record still lists
NCT06342973 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Alveolar Ridge Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Xenograft and allograft is the first listed.
NCT06342973 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT06342973 about?
NCT06342973 is a clinical study titled "Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study". The aim of this case series is to evaluate the outcomes of horizontal ridge augmentation performed using a combination of demineralized freeze-dried bone allograft layered with xenograft bone with a resorbable native collagen membrane.
What is the current status of trial NCT06342973?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2024-03-27. Estimated completion is 2025-10-15.
What conditions does trial NCT06342973 study?
This clinical trial studies the following conditions: Alveolar Ridge Deficiency.
What interventions are being tested in trial NCT06342973?
The interventions under investigation include: Xenograft and allograft (DEVICE).
Who is sponsoring clinical trial NCT06342973?
This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 45 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06342973 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06342973's enrollment target sits among peer trials
15 1881st of 2000 higher than 100 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI